Table 1.
HBsAg n (%) | Anti HCV n (%) | |
---|---|---|
General population (n:5465) | 218 (3.99)* | 52 (0.95) |
RA (n:1517) | 35 (2.3) | 17 (1.1) |
AS (n:886) | 27 (3) | 10 (1.1) |
p<0.01; * vs. RA and AS patients.
HBsAg: hepatitis B virus surface antigen; anti-HCV: hepatitis C virus antibody; RA: rheumatoid arthritis; AS: ankylosing spondylitis